10 results on '"Oscar Rodriguez Faba"'
Search Results
2. Robotic kidney transplantation: one year after the beginning
- Author
-
Jorge Caffaratti, Carme Facundo, Javier Ponce de León, Marco Guazzieri, Humberto Villavicencio, Andrea Guttilla, Lluis Guirado, Alberto Breda, Oscar Rodriguez-Faba, Angelo Territo, and Lluis Gausa
- Subjects
Adult ,Male ,medicine.medical_specialty ,Urology ,030232 urology & nephrology ,Pilot Projects ,Anastomosis ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Robotic Surgical Procedures ,Suture (anatomy) ,Blood loss ,Intraperitoneal hematoma ,Humans ,Medicine ,Prospective Studies ,Kidney transplantation ,business.industry ,Patient Selection ,Laparoscopic nephrectomy ,Recovery of Function ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Thrombosis ,Surgery ,Transplantation ,Treatment Outcome ,Spain ,030220 oncology & carcinogenesis ,Kidney Failure, Chronic ,Female ,business - Abstract
Kidney transplantation (KT) is the preferred treatment for patients with end-stage renal disease (ESRD). To reduce the morbidity of the open surgery, a robotic-assisted approach has been recently introduced. Our aim is to evaluate surgical and functional results on 17 cases of robotic-assisted kidney transplantation (RAKT) performed at the same institution. From July 2015 to June 2016, we performed 17 cases of RAKT from living donors in pre-emptive patients, who underwent laparoscopic nephrectomy. A prospective pilot study was made at Fundacio Puigvert (Barcelona), evaluating functional and surgical outcomes. In this series, we considered the functional results, surgical outcomes and complications rates. Seventeen patients successfully underwent RAKT, in particular surgical console time was 181 min (150–200) with vascular suture time 42 min (32–48), and estimated blood loss
- Published
- 2017
3. American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy
- Author
-
Mario Alvarez-Maestro, Marcelo Featherston, Oscar Rodriguez Faba, Rene Sotelo, Alberto Jurado Navarro, Oscar Schatloff, Patricio García Marchiñena, Pablo Holst, Luis Martínez-Piñeiro, José Cocisfran Alves Milfont, Ivar Vidal-Mora, Alberto Villaronga, Gustavo Villoldo, J. Rozanec, Juan Ignacio Monzó Gardiner, Hugo Dávila, Octavio A. Castillo, Victor T. Dubeux, Diego Abreu Clavijo, Fernando P. Secin, Ricardo Decia, Stênio de Cássio Zequi, Gustavo Cardoso Guimarães, Anamaria Autran, Andres Hernández-Porrás, Rodrigo Frota, Joan Palou, Humberto Villavicencio Mavric, Félix Santaella-Torres, Luciano A. Nunez Bragayrac, Agustin Rovegno, Diana Finkelstein, R. Sanchez-Salas, and Emilio T. Quesada
- Subjects
Male ,Nephrology ,Databases, Factual ,medicine.medical_treatment ,Blood Loss, Surgical ,030232 urology & nephrology ,Kaplan-Meier Estimate ,Nephrectomy ,Postoperative Complications ,0302 clinical medicine ,Robotic Surgical Procedures ,Adenoma, Oxyphilic ,Partial nephrectomy ,Warm Ischemia ,Laparoscopy ,medicine.diagnostic_test ,Margins of Excision ,Kidney cancer ,Middle Aged ,Conversion to Open Surgery ,Kidney Neoplasms ,Tumor Burden ,030220 oncology & carcinogenesis ,Female ,medicine.medical_specialty ,Urology ,Angiomyolipoma ,Operative Time ,03 medical and health sciences ,Internal medicine ,medicine ,Hand-Assisted Laparoscopy ,Humans ,Minimally Invasive Surgical Procedures ,Carcinoma, Renal Cell ,Mexico ,Aged ,Neoplasm Staging ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Postoperative complication ,Perioperative ,Length of Stay ,South America ,medicine.disease ,Confidence interval ,Surgery ,Nephron sparing ,Logistic Models ,Spain ,Multivariate Analysis ,business - Abstract
To describe the perioperative and oncology outcomes in a series of laparoscopic or robotic partial nephrectomies (PN) for renal tumors treated in diverse institutions of Hispanic America from the beginning of their minimally invasive (MI) PN experience through December 2014. Seventeen institutions participated in the CAU generated a MI PN database. We estimated proportions, medians, 95 % confidence intervals, Kaplan-Meier curves, multivariate logistic and Cox regression analyses. Clavien-Dindo classification was used. We evaluated 1501 laparoscopic (98 %) or robotic (2 %) PNs. Median age: 58 years. Median surgical time, warm ischemia and intraoperative bleeding were 150, 20 min and 200 cc. 81 % of the lesions were malignant, with clear cell histology being 65 % of the total. Median maximum tumor diameter is 2.7 cm, positive margin is 8.2 %, and median hospitalization is 3 days. One or more postoperative complication was recorded in 19.8 % of the patients: Clavien 1: 5.6 %; Clavien 2: 8.4 %; Clavien 3A: 1.5 %; Clavien 3B: 3.2 %; Clavien 4A: 1 %; Clavien 4B: 0.1 %; Clavien 5: 0 %. Bleeding was the main cause of a reoperation (5.5 %), conversion to radical nephrectomy (3 %) or open partial nephrectomy (6 %). Transfusion rate is 10 %. In multivariate analysis, RENAL nephrometry score was the only variable associated with complications (OR 1.1; 95 % CI 1.02-1.2; p = 0.02). Nineteen patients presented disease progression or died of disease in a median follow-up of 1.37 years. The 5-year progression or kidney cancer mortality-free rate was 94 % (95 % CI 90, 97). Positive margins (HR 4.98; 95 % CI 1.3-19; p = 0.02) and females (HR 5.6; 95 % CI 1.7-19; p = 0.005) were associated with disease progression or kidney cancer mortality after adjusting for maximum tumor diameter. Laparoscopic PN in these centers of Hispanic America seem to have acceptable perioperative complications and short-term oncologic outcomes.
- Published
- 2016
4. Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion
- Author
-
George N. Thalmann, Bernard H. Bochner, Mark D. Tyson, Richard E. Hautmann, Ella C Skinner, Oscar Rodriguez Faba, Joan Palou, Stephan Madersbacher, Roland Seiler, Joachim W. Thüroff, Fiona C. Burkhard, Tilman Kälble, Walter Artibani, Scott M. Gilbert, and Peter Wiklund
- Subjects
medicine.medical_specialty ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,610 Medicine & health ,Controlled studies ,Urinary Diversion ,Cystectomy ,Expert committee ,Radical cystectomy and complications ,03 medical and health sciences ,0302 clinical medicine ,Postoperative Complications ,Robotic Surgical Procedures ,Medicine ,Humans ,Robotic surgery ,Urinary diversion ,Neoplasm Invasiveness ,Carcinoma, Transitional Cell ,Modalities ,Bladder cancer ,business.industry ,General surgery ,Urinary Reservoirs, Continent ,Urological Diseases ,Muscle, Smooth ,medicine.disease ,Urinary Bladder Neoplasms ,030220 oncology & carcinogenesis ,Fast track ,business ,MIBC and urinary diversions - Abstract
PURPOSE To provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Société Internationale d'Urologie on Bladder Cancer Urinary Diversion (UD). METHODS A detailed analysis of the literature was conducted reporting on the different modalities of UD. For this updated publication, an exhaustive search was conducted in PubMed for recent relevant papers published between October 2013 and August 2018. Via this search, a total of 438 references were identified and 52 of them were finally eligible for analysis. An international, multidisciplinary expert committee evaluated and graded the data according to the Oxford System of Evidence-based Medicine. RESULTS The incidence of early complications has been reported retrospectively in the range of 20-57%. Unfortunately, only a few randomized controlled studies exist within the field of UD. Consequently, almost all studies used in this report are of level 3-4 evidence including expert opinion based on "first principles" research. CONCLUSIONS Complications rates overall following RC and UD are significant, and when strict reporting criteria are incorporated, they are much higher than previously published. Complications can occur up to 20 years after surgery, emphasizing the need for lifelong follow-up. Progress has been made to prevent complications implementing robotic surgery and fast track protocols. Preoperative patient information, patient selection, surgical techniques, and careful postoperative follow-up are the cornerstones to achieve good results.
- Published
- 2018
5. Mini-laparoscopic live donor nephrectomy with the use of 3-mm instruments and laparoscope
- Author
-
Humberto Villavicencio, Esteban Emiliani, Oscar Rodriguez-Faba, Lluís Gausa, Xavier Ponce de León, Alberto Breda, I. Schwartzmann, and Jorge Caffaratti
- Subjects
Male ,Nephrology ,medicine.medical_specialty ,Time Factors ,Urology ,Population ,Cosmetic Techniques ,Kidney ,Nephrectomy ,Severity of Illness Index ,Cicatrix ,Patient satisfaction ,Internal medicine ,Living Donors ,medicine ,Humans ,Kidney surgery ,Laparoscopy ,education ,Kidney transplantation ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Incidence ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Laparoscopes ,Surgery ,Incision Site ,Patient Satisfaction ,Female ,business ,Follow-Up Studies - Abstract
To analyze our preliminary outcomes on the use of 3 mm instruments for laparoscopic live donor nephrectomy (LLDN). Our series includes thirteen patients, who underwent LLDN using 3-mm instruments and laparoscope and 5-mm transumbilical trocar. The patients were followed at 7 and 14 days from discharge and were specifically asked about their cosmetic satisfaction. At follow-up, the recipient graft function was controlled, as well as the donor’s cosmetic results. Eight months after surgery, all thirteen patients were asked to fill out the Patient Scar Assessment Questionnaire and Scoring System (PSAQ). All patients presented good recovery after surgery. Regarding cosmetic outcomes, the donors expressed their satisfaction toward the minimal incision size and optimal esthetic results at 7 and 14 days from discharge home. The low scores on each section of the PSAQ confirmed the favorable outcomes. Early graft function was satisfactory at 1 and 3 months after the kidney transplantation. Furthermore, there were no major complications in the recipients. Our persistent positive results with the use of 3-mm instruments during LLDN support this technique as a good alternative to the standard laparoscopic approach for minimizing the incision site, while maintaining safety and excellent clinical outcomes. The fact that the general laparoscopic standards are maintained could make this approach a very attractive alternative to the other minimally invasive approaches for live donor nephrectomy. The hope is in that the higher degree of satisfaction in the donor population demonstrated in this study may likely enhance living kidney donation.
- Published
- 2014
6. High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment
- Author
-
Oscar Rodriguez Faba, Alberto Breda, Humberto Villavicencio, and Joan Palou
- Subjects
Male ,Oncology ,Nephrology ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Cystectomy ,Resection ,Neoplasm Recurrence ,Risk Factors ,Internal medicine ,medicine ,Carcinoma ,Humans ,Aged ,Carcinoma, Transitional Cell ,Bladder cancer ,business.industry ,Standard treatment ,Disease Management ,Middle Aged ,Prognosis ,medicine.disease ,Mycobacterium bovis ,Early Diagnosis ,Treatment Outcome ,Urinary Bladder Neoplasms ,Female ,Neoplasm Recurrence, Local ,business ,Non muscle invasive ,Adjuvant - Abstract
Despite standard treatment with transurethral resection (TUR) and adjuvant bacillus Calmette-Guérin (BCG), many high-risk bladder cancers (HRBCs) recur and some progress. Based on a review of the literature, we aimed to establish the optimal current approach for the early diagnosis and management of HRBC.A MEDLINE® search was conducted to identify the published literature relating to early identification and treatment for non-muscle-invasive bladder cancer. Particular attention was paid to factors such as quality of TUR, importance of second TUR, substaging, and CIS. In addition, studies on urinary markers, photodynamic diagnosis, predictive clinical and molecular factors for recurrence and progression after BCG, and best management practice were analysed.Good quality of TUR and the implementation of photodynamic diagnosis in selected cases provide a more accurate diagnosis and reduce the risk of residual tumour in HRBC. Although insufficient evidence is available to warrant the use of new urinary molecular markers in isolation, their use in conjunction with cytology and cystoscopy may improve early diagnosis and follow-up. BCG plus maintenance for at least 1 year remains the standard adjuvant treatment for HRBC. Moreover, there is enough evidence to consider the implementation of new specific risk tables for patients treated with BCG. In HRBC patients with poor prognostic factors after TUR, early cystectomy should be considered.
- Published
- 2012
7. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma
- Author
-
Marco Cosentino, Josep M Gaya, Oscar Rodriguez-Faba, Joan Palou, Alberto Breda, and Humberto Villavicencio-Mavrich
- Subjects
Male ,Nephrology ,Oncology ,medicine.medical_specialty ,Concomitant ,Urology ,Kidney Calices ,Neoplasms, Multiple Primary ,Risk Factors ,Internal medicine ,medicine ,Carcinoma ,Humans ,Kidney Pelvis ,Cancer recurrence ,Aged ,Retrospective Studies ,Upper urinary tract ,Carcinoma, Transitional Cell ,Bladder cancer ,Ureteral Neoplasms ,business.industry ,Incidence (epidemiology) ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Kidney Neoplasms ,Neck of urinary bladder ,Urinary Bladder Neoplasms ,Risk factors ,Upper tract urothelial carcinoma ,Female ,business - Abstract
To investigate the existence of predictive factors for concomitant, primary UUT-UCC and BC. Upper urinary tract urothelial cell carcinoma (UUT-UCC) is a pan-urothelial disease of the transitional epithelial cells. Although several studies have shown the association of bladder recurrence following UUT-UCC, little is known on the incidence of concomitant UUT-UCC and bladder cancer (BC) without previous BC. A retrospective review of 673 patients diagnosed and treated for UUT-UCC was performed. Patients with history of BC were excluded. We investigated age, sex, location of the upper tract tumor (calyx, renal pelvis, upper ureter, mid-ureter, lower ureter), multifocality, clinical symptoms, tumor grade and pathological stage. Contingency tables and chi-square test were used for categorical variables and analysis of variance (ANOVA) for quantitative variables. 450 patients eligible for inclusion were identified. Of these, 76 (17 %) presented concomitant primary UUT-UCC and BC. Location of primary UUT-UCC was in calyx and/or renal pelvis in 25 patients (34 %), upper ureter 8 (11 %) and lower ureter 37 (49 %). In 6 patients (8 %), data were missing. Concomitant BC was found in 10, 18, and 33 % of patients with primary caliceal/renal pelvis, upper ureter and lower ureter UUT-UCC, respectively. On multivariate analysis, location of UUT-UCC was the only predictive factor for concomitant bladder tumor (OR: 1.7; 95 % CI, 1.007-2.906 p = 0.047). Our findings suggest that the possibility of concomitant BC in primary diagnosed patient with UUT-UCC is as high as 33 % and mainly depends on upper tract tumor location.
- Published
- 2012
8. Robotic-assisted kidney transplantation: our first case
- Author
-
L. Guirado, Oscar Rodriguez-Faba, J. Caffaratti, J. Ponce de León, Humberto Villavicencio, J. M. López-Martínez, Alberto Breda, L. Gausa, and Angelo Territo
- Subjects
Nephrology ,Adult ,medicine.medical_specialty ,Tissue and Organ Procurement ,Robotic assisted ,Urology ,medicine.medical_treatment ,Operative Time ,030232 urology & nephrology ,Nephrectomy ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Living Donors ,Humans ,Robotic surgery ,Laparoscopy ,Kidney transplantation ,Kidney ,Creatinine ,medicine.diagnostic_test ,business.industry ,Robotics ,medicine.disease ,Kidney Transplantation ,Surgery ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Kidney Failure, Chronic ,Female ,business ,Follow-Up Studies - Abstract
Kidney transplantation is the preferred treatment for patients with end-stage renal disease. In order to reduce the morbidity of the open surgery, a robotic-assisted approach has been recently introduced. According to the published literature, the robotic surgery allows the performance of kidney transplantation under optimal operative conditions while maintaining the safety and the functional results of the open approach. We present the case of a mother donating to her daughter affected by end-stage renal disease (ESRD) due to Alport disease (creatinine: 353 umol/l; GFR: 13 ml/min per 1.73 m2). A robotic-assisted kidney transplant (RAKT) was successfully performed. Surgical time was 120 min with 53 min for vascular suture. The estimated blood loss was
- Published
- 2015
9. Erratum to: Editorial for a special issue on kidney transplant
- Author
-
Oscar Rodriguez Faba and Alberto Breda
- Subjects
Nephrology ,medicine.medical_specialty ,business.industry ,Urology ,Internal medicine ,General surgery ,medicine ,business ,Kidney transplant - Published
- 2014
10. Erratum to: Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
- Author
-
Loreto Gesualdo, Michele Battaglia, Oscar Rodriguez-Faba, Carlo Bettocchi, C Facundo, Juan Palou, Giuseppe Lucarelli, Luis Guirado, Humberto Villavicencio, Alberto Breda, Giuseppe Grandaliano, Pasquale Ditonno, and Giuseppe Castellano
- Subjects
education.field_of_study ,medicine.medical_specialty ,business.industry ,Urology ,Population ,Retrospective cohort study ,Disease ,urologic and male genital diseases ,medicine.disease ,female genital diseases and pregnancy complications ,End stage renal disease ,Increased risk ,Renal cell carcinoma ,medicine ,education ,business ,Pathological ,Kidney transplantation - Abstract
Purpose Patients with end-stage renal disease (ESRD) have an increased risk of developing renal cell carcinoma (RCC). This retrospective study compared clinical and pathological outcomes of RCC occurring in native kidneys of patients with ESRD (whether they underwent kidney transplantation or not) with those of renal tumors diagnosed in the general population.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.